India can easily do synthesis of antiviral drug - Remdesivir: Former ICMR Director
May 02, 2020
New Delhi [India], May 3 : India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma major Gilead Sciences, said Dr Nirmal K Ganguly, former Director-General, Indian Council of Medical Research (ICMR), on Saturday.